APOTHEEK BLANCKAERT
Board
1 director, last change in January 2026REMEDIUM CommV
Director (not named in the articles), permanent representative BLANCKAERT Thibaut
appointed by deed of 07-01-2026
term without a fixed end
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 30-01-2026
Permanent representatives 1
Mandates through the years
3 names, the dashed line is todayREMEDIUM
Director (not named in the articles)
Director (not named in the articles)
An Vandecasteele
Director
Director
Wim Vannecke
Statutory director
Statutory director
BoardEarliermandate already running before its first mention
Mandates as a list
- REMEDIUM
- Director (not named in the articles), appointed by deed of 07-01-2026, still in office
- An Vandecasteele
- Director, from 15-03-2013 to 07-01-2026
- Director, until 30-01-2026
- Wim Vannecke
- Statutory director, from 10-08-1995 to 30-01-2026
Control
Shareholder
Enige aandeelhouder
This company
APOTHEEK BLANCKAERT
Equity €157,451
Profit €119,858 in 2025
Capital
- Contribution
- €18,600
- Source
- 2025 annual accounts
Articles of association
deed of 30-01-2026 (in Dutch)- Board ruleThese rules set how the board is made up, meets and takes decisions.
- At least 1 director
- Financial yearThe company draws up its annual accounts over this twelve-month period.
- From 1 January to 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- Third Tuesday of June at 14:00
Shareholders
Stated in the deed
deed of 30-01-2026 ↗
- Enige aandeelhouder all shares